News

September 18, 2022 — PALO ALTO, Calif.- ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., today announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating the endovascular...

FEops HEARTguide significantly improves efficiency and outcomes of LAAO procedures in the PREDICT-LAA Randomized Clinical Trial

Five late-breaking presentations at TCT 2022 highlight the impact of Abbott's structural heart devices to repair or replace heart valves and close openings in the heart New data reinforce the safety and effectiveness of MitraClip™ for...

Patent Opens Pathway to a Disruptive Ischemia and Arrhythmia Detection ECG Patch Product.

Obese women who use oral contraceptives containing oestrogen and progestin have a 24-fold increased risk of venous thromboembolism (VTE) compared with non-obese women not using the drugs.

Stereotaxis announced that Overland Park Regional Medical Center (OPRMC) is establishing its second robotic program for the treatment of heart rhythm disorders.

Study suggests prescribing Philips MCOT (Mobile Cardiac Outpatient Telemetry) solution may support improved patient outcomes and cost savings by monitoring for arrhythmic disturbances and encouraging timely intervention.

Annuloplasty device demonstrates advantage of 2-stage approach using a device specifically designed for the tricuspid heart valve.

Innovative Health, LLC, a specialty cardiology reprocessor, announced today that it has become the first supplier to be fully engaged with the standards of the Healthcare Industry Resilience Collaborative.

The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary artery in a 52- year-old patient.